Parathyroid scintigraphy findings in chronic kidney disease patients with recurrent hyperparathyroidism

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 3, 2010, Pages 623-634

  Hindie, Elif ^a   Zanotti Fregonara, Paolo ^b   Just, Pierre Alexandre ^a   Sarfati, Emile ^a   Mellière, Didier ^c   Toubert, Marie Elisabeth ^a   Moretti, Jean Luc ^a   Jeanguillaume, Christian ^d   Keller, Isabelle ^b   Ureña Torres, Pablo ^e  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITÉ D'ANGERS   (France)

^e Clinique du Landy   (France)

Author keywords

CKD; Imaging studies; Parathyroid scintigraphy; Parathyroidectomy; Recurrent; Reoperative surgery; Secondary hyperparathyroidism; Sestamibi scanning; Subtraction scanning; Surgery

Indexed keywords

IODINE 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEMODIALYSIS PATIENT; HUMAN; HYPERPARATHYROIDISM; KIDNEY GRAFT; MALE; PARATHYROID DISEASE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; PARATHYROMATOSIS; RECURRENT DISEASE; REFRACTORY RENAL HYPERPARATHYROIDISM; RELAPSE; REOPERATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUPERNUMERARY PARATHYROID GLAND;

ADULT; AGED; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM; KIDNEY DISEASES; MALE; MIDDLE AGED; PARATHYROID GLANDS; RECURRENCE; SENSITIVITY AND SPECIFICITY;

EID: 77949267063     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1313-8     Document Type: Article

References (75)

1. J Silver T Naveh-Many 2009 Phosphate and the parathyroid Kidney Int 75 898 905 10.1038/ki.2008.642 1:CAS:528:DC%2BD1MXks1Sjtrk%3D 19129794
2. O Gutierrez T Isakova E Rhee A Shah J Holmes G Collerone, et al. 2005 Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease J Am Soc Nephrol 16 2205 2215 10.1681/ASN.2005010052 1:CAS:528:DC%2BD2MXms1egsLs%3D 15917335 (Pubitemid 41716454)
3. D Prié P Ureña Torres G Friedlander 2009 Latest findings in phosphate homeostasis Kidney Int 75 882 889 10.1038/ki.2008.643 19190675
4. A Arnold MF Brown P Ureña RD Gaz E Sarfati TB Drüeke 1995 Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia J Clin Invest 95 2047 2053 10.1172/JCI117890 1:CAS:528:DyaK2MXltlWrtrk%3D 7738171
5. AM Parfitt 1997 The hyperparathyroidism of chronic renal failure: a disorder of growth Kidney Int 52 3 9 10.1038/ki.1997.297 1:STN:280: DyaK2szlsFWntw%3D%3D 9211340
6. H Komaba M Tanaka M Fukagawa 2008 Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Intern Med 47 989 994 10.2169/internalmedicine.47.1051 18520108
7. SK Ganesh AG Stack NW Levin T Hulbert-Shearon FK Port 2001 Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 2131 2138 1:CAS:528:DC%2BD3MXnsFWiurk%3D 11562412
8. MP Marco L Craver A Betriu M Belart J Fibla E Fernández 2003 Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population Kidney Int Suppl 85 S111 S114 10.1046/j.1523-1755.63. s85.26.x 12753279
9. GA Block PS Klassen JM Lazarus N Ofsthun EG Lowrie GM Chertow 2004 Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2208 2218 10.1097/01.ASN.0000133041.27682.A2 1:CAS:528: DC%2BD2cXlvVKmu7w%3D 15284307 (Pubitemid 39031360)
10. F Tentori MJ Blayney JM Albert BW Gillespie PG Kerr J Bommer, et al. 2008 Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 52 519 530 10.1053/j.ajkd.2008.03.020 1:CAS:528: DC%2BD1cXhtFOrt7zF 18514987
11. WG Goodman J Goldin BD Kuizon C Yoon B Gales D Sider, et al. 2000 Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 1478 1483 10.1056/NEJM200005183422003 1:STN:280:DC%2BD3c3ls1OjtA%3D%3D 10816185 (Pubitemid 30318271)
12. P Raggi A Boulay S Chasan-Taber N Amin M Dillon SK Burke, et al. 2002 Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39 695 701 10.1016/S0735-1097(01)01781-8 11849871 (Pubitemid 34158168)
13. SM Moe NX Chen 2008 Mechanisms of vascular calcification in chronic kidney disease J Am Soc Nephrol 19 213 216 10.1681/ASN.2007080854 1:CAS:528:DC%2BD1cXivFKqsb4%3D 18094365 (Pubitemid 351240642)
14. M Jadoul JM Albert T Akiba T Akizawa L Arab JL Bragg-Gresham, et al. 2006 Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study Kidney Int 70 1358 1366 10.1038/sj.ki.5001754 1:STN:280:DC%2BD28rmt1OlsA%3D%3D 16929251 (Pubitemid 44435190)
15. JA Girotto JW Harmon LE Ratner TL Nicol L Wong H Chen 2001 Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism Surgery 130 645 650 10.1067/msy.2001.117101 1:STN:280:DC%2BD3Mrls1Whug%3D%3D 11602895 (Pubitemid 32964610)
16. R Jofré JM López Gómez J Menárguez JR Polo M Guinsburg T Villaverde, et al. 2003 Parathyroidectomy: whom and when? Kidney Int Suppl 85 S97 S100 10.1046/j.1523-1755.63.s85.23.x 12753276
17. Y Tominaga S Matsuoka N Uno 2009 Surgical and medical treatment of secondary hyperparathyroidism in patients on continuous dialysis World J Surg 33 2335 2342 10.1007/s00268-009-9943-3 19247704
18. PU Torres D Prié L Beck G Friedlander 2006 New therapies for uremic secondary hyperparathyroidism J Ren Nutr 16 87 99 10.1053/j.jrn.2006.01. 011 16567265
19. GA Block KJ Martin AL de Francisco SA Turner MM Avram MG Suranyi, et al. 2004 Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis N Engl J Med. 350 1516 1525 10.1056/NEJMoa031633 1:CAS:528:DC%2BD2cXjtVeqtLY%3D 15071126 (Pubitemid 38477776)
20. P Evenepoel 2008 Calcimimetics in chronic kidney disease: evidence, opportunities and challenges Kidney Int 74 265 275 10.1038/ki.2008.166 1:CAS:528:DC%2BD1cXosVOht7Y%3D 18528328 (Pubitemid 352001237)
21. TB Drüeke E Ritz 2009 Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives Clin J Am Soc Nephrol 4 234 241 10.2215/CJN.04520908 19056615
22. National Kidney Foundation 2003 K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease Am J Kidney Dis 42 4 Suppl 3 S1 S201
23. S Fishbane WB Shapiro DB Corry SL Vicks M Roppolo K Rappaport, et al. 2008 Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results Clin J Am Soc Nephrol 3 1718 1725 10.2215/CJN.01040308 1:CAS:528:DC%2BD1cXhsVKmsLnF 18945995
24. RN Foley S Li J Liu DT Gilbertson SC Chen AJ Collins 2005 The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002 J Am Soc Nephrol 16 210 218 10.1681/ASN.2004020138 15563573 (Pubitemid 43073175)
25. ER Gagné P Ureña S Leite-Silva J Zingraff A Chevalier E Sarfati, et al. 1992 Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients J Am Soc Nephrol 3 1008 1017 1450363
26. ML Richards J Wormuth J Bingener K Sirinek 2006 Parathyroidectomy in secondary hyperparathyroidism: is there an optimal operative management? Surgery 139 174 180 10.1016/j.surg.2005.08.036 16455325 (Pubitemid 43170317)
27. JL Pasieka LL Parsons 2000 A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism Surgery 128 531 539 10.1067/msy.2000.108117 1:STN:280:DC%2BD3M%2Fhsl2gtQ%3D%3D 11015085 (Pubitemid 30764637)
28. M Milas CJ Weber 2004 Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism Surgery 136 1252 1260 10.1016/j.surg.2004.06.055 15657584 (Pubitemid 39647542)
29. KD Rudser IH de Boer A Dooley B Young B Kestenbaum 2007 Fracture risk after parathyroidectomy among chronic hemodialysis patients J Am Soc Nephrol 18 2401 2407 10.1681/ASN.2007010022 17634437 (Pubitemid 47203856)
30. AJ Bleyer J Burkart M Piazza G Russell M Rohr JJ Carr 2005 Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD Am J Kidney Dis 46 464 469 10.1053/j.ajkd.2005.04.035 16129208 (Pubitemid 41208182)
31. G Coen S Calabria G Bellinghieri F Pecchini F Conte MG Chiappini, et al. 2001 Parathyroidectomy in chronic renal failure: short- and long-term results on parathyroid function, blood pressure and anemia Nephron 88 149 155 10.1159/000045976 1:STN:280:DC%2BD3Mzjt1Wlug%3D%3D 11399918 (Pubitemid 32588869)
32. T Sato Y Tominaga T Ueki N Goto S Matsuoka A Katayama, et al. 2004 Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism Am J Kidney Dis 44 481 487 10.1016/S0272-6386(04)00817-0 1:CAS:528:DC%2BD2cXnvVGnur8%3D 15332221
33. OM Gutiérrez M Mannstadt T Isakova JA Rauh-Hain H Tamez A Shah, et al. 2008 Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 584 592 10.1056/NEJMoa0706130 18687639
34. N Goto Y Tominaga S Matsuoka T Sato A Katayama T Haba, et al. 2005 Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy Clin Exp Nephrol 9 138 141 10.1007/s10157-005-0351-1 15980948 (Pubitemid 40875103)
35. B Kestenbaum DL Andress SM Schwartz DL Gillen SL Seliger PR Jadav, et al. 2004 Survival following parathyroidectomy among United States dialysis patients Kidney Int 66 2010 2016 10.1111/j.1523-1755.2004.00972.x 15496173
36. V Costa-Hong V Jorgetti LH Gowdak RM Moyses EM Krieger JJ De Lima 2007 Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism Surgery 142 699 703 10.1016/j.surg.2007.06.015 17981190 (Pubitemid 350018846)
37. B Dussol P Morand C Martinat E Lombard H Portugal P Brunet, et al. 2007 Influence of parathyroidectomy on mortality in hemodialysis patients: a prospective observational study Ren Fail 29 579 586 10.1080/08860220701392447 1:CAS:528:DC%2BD2sXotV2ksrY%3D 17654321 (Pubitemid 47123826)
38. F Triponez OH Clark Y Vanrenthergem P Evenepoel 2008 Surgical treatment of persistent hyperparathyroidism after renal transplantation Ann Surg 248 18 30 10.1097/SLA.0b013e3181728a2d 18580203
39. M Rothmund PK Wagner 1988 Reoperations for persistent and recurrent secondary hyperparathyroidism Ann Surg 207 310 314 10.1097/00000658-198803000- 00014 1:STN:280:DyaL1c7kvFWgug%3D%3D 3345116 (Pubitemid 18088987)
40. M Kessler JM Avila E Renoult P Mathieu 1991 Reoperation for secondary hyperparathyroidism in chronic renal failure Nephrol Dial Transplant 6 176 179 1:STN:280:DyaK3Mzis1aqsA%3D%3D 1866046
41. D Seehofer T Steinmüller N Rayes P Podrabsky J Riethmüller J Klupp, et al. 2004 Parathyroid hormone venous sampling before reoperative surgery in renal hyperparathyroidism: comparison with noninvasive localization procedures and review of the literature Arch Surg 139 1331 138 10.1001/archsurg.139.12.1331 15613292 (Pubitemid 39602858)
42. G Gasparri M Camandona GC Abbona M Papotti A Jeantet E Radice, et al. 2001 Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies Ann Surg 233 65 69 10.1097/00000658-200101000- 00011 1:STN:280:DC%2BD3MzltlWqtg%3D%3D 11141227 (Pubitemid 32042777)
43. FF Chou CH Lee HY Chen JB Chen KT Hsu SM Sheen-Chen 2002 Persistent and recurrent hyperparathyroidism after total parathyroidectomy with autotransplantation Ann Surg 235 99 104 10.1097/00000658-200201000-00013 11753048 (Pubitemid 34062405)
44. C Dotzenrath K Cupisti E Goretzki A Mondry A Vossough B Grabensee, et al. 2003 Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients Langenbecks Arch Surg 387 348 354 1:STN:280:DC%2BD3s%2FivVKquw%3D%3D 12536330
45. S Stracke F Keller G Steinbach D Henne-Bruns P Wuerl 2009 Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism Nephron Clin Pract 111 c102 c109 10.1159/000191200 1:CAS:528:DC%2BD1MXisFequ7w%3D 19142022
46. P Cattan B Halimi K Aïdan C Billotey C Tamas TB Drüeke, et al. 2000 Reoperation for secondary uremic hyperparathyroidism: are technical difficulties influenced by initial surgical procedure? Surgery 127 562 565 10.1067/msy.2000.105865 1:STN:280:DC%2BD3c3nvFSgtQ%3D%3D 10819065
47. E Hindié D Mellière C Jeanguillaume L Perlemuter F Chéhadé P Galle 1998 Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123 J Nucl Med 39 1100 1105 9627353
48. V Donckier C Decoster-Gervy P Kinnaert 1997 Long-term results after surgical treatment of renal hyperparathyroidism when fewer than four glands are identified at operation J Am Coll Surg 184 70 74 1:STN:280:DyaK2s7ktlaqsA%3D%3D 8989303
49. P Kinnaert C Tielemans M Dhaene C Decoster-Gervy 1998 Evaluation of surgical treatment of renal hyperparathyroidism by measuring intact parathormone blood levels on first postoperative day World J Surg 22 695 699 10.1007/s002689900455 1:STN:280:DyaK1c3ntV2ktw%3D%3D 9606284 (Pubitemid 28277864)
50. G Akerström J Malmaeus R Bergström 1984 Surgical anatomy of human parathyroid glands Surgery 95 14 21 6691181
51. S Matsuoka Y Tominaga T Sato N Uno N Goto A Katayama, et al. 2007 QuiCk-IntraOperative Bio-Intact PTH assay at parathyroidectomy for secondary hyperparathyroidism World J Surg 31 824 831 10.1007/s00268-006-0601-8 17354020 (Pubitemid 46496221)
52. FN Pattou LC Pellissier C Noël F Wambergue DG Huglo CA Proye 2000 Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism World J Surg 24 1330 1334 10.1007/s002680010220 1:STN:280:DC%2BD3M%2FlslKhug%3D%3D 11038202 (Pubitemid 30836881)
53. N Uno Y Tominaga S Matsuoka T Tsuzuki S Shimabukuro T Sato, et al. 2008 Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism World J Surg. 32 2516 2519 10.1007/s00268-008-9739-x 18795242
54. RD Gaz PB Doubler CA Wang 1987 The management of 50 unusual hyperfunctioning parathyroid glands Surgery 102 949 957 1:STN:280: DyaL1c%2FntFagsw%3D%3D 3686358
55. KE Levin OH Clark 1989 The reasons for failure in parathyroid operations Arch Surg 124 911 914 1:STN:280:DyaL1MzjsVGquw%3D%3D 2757503
56. KG Billingsley DL Fraker JL Doppman JA Norton TH Shawker MC Skarulis, et al. 1994 Localization and operative management of undescended parathyroid adenomas in patients with persistent primary hyperparathyroidism Surgery 116 982 989 1:STN:280:DyaK2M%2Fns1ersA%3D%3D 7985106
57. S Matsuoka Y Tominaga N Uno N Goto T Sato A Katayama, et al. 2006 Surgical significance of undescended parathyroid gland in renal hyperparathyroidism Surgery 139 815 820 10.1016/j.surg.2005.10.017 16782439 (Pubitemid 43922373)
58. TM Pawlik M Richards TJ Giordano R Burney N Thompson 2001 Identification and management of intravagal parathyroid adenoma World J Surg 25 419 423 10.1007/s002680020067 1:STN:280:DC%2BD3M3kt1ersg%3D%3D 11344391 (Pubitemid 32455191)
59. D Axelrod JC Sisson K Cho J Miskulin PG Gauger 2003 Appearance of ectopic undescended inferior parathyroid adenomas on technetium Tc 99m sestamibi scintigraphy: a lesson from reoperative parathyroidectomy Arch Surg 138 1214 1218 10.1001/archsurg.138.11.1214 14609869 (Pubitemid 37392395)
60. PF Alesina D Moka J Mahlstedt MK Walz 2008 Thoracoscopic removal of mediastinal hyperfunctioning parathyroid glands: personal experience and review of the literature World J Surg 32 224 231 10.1007/s00268-007-9303-0 1:STN:280:DC%2BD1c%2Flt1Sntw%3D%3D 18064517
61. C Stehman-Breen N Muirhead D Thorning D Sherrard 1996 Secondary hyperparathyroidism complicated by parathyromatosis Am J Kidney Dis 28 502 507 10.1016/S0272-6386(96)90459-X 1:STN:280:DyaK28vjvVGkug%3D%3D 8840938
62. S Matsuoka Y Tominaga T Sato N Uno N Goto A Katayama, et al. 2007 Recurrent renal hyperparathyroidism caused by parathyromatosis World J Surg 31 299 305 10.1007/s00268-006-0391-z 17219279 (Pubitemid 46183513)
63. E Hindié P Urenã C Jeanguillaume D Mellière JM Berthelot V Menoyo-Calonge, et al. 1999 Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism Lancet 353 2200 2204 10.1016/S0140-6736(98)09089-8 10392985 (Pubitemid 29295253)
64. JV Torregrosa L Fernández-Cruz A Canalejo S Vidal E Astudillo Y Almaden, et al. 2000 (99m)Tc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism World J Surg 24 1386 1390 10.1007/s002680010229 1:STN:280:DC%2BD3M%2FlslKgtQ%3D%3D 11038211 (Pubitemid 30836890)
65. S Périé H Fessi M Tassart N Younsi I Poli JL St Guily, et al. 2005 Usefulness of combination of high-resolution ultrasonography and dual-phase dual-isotope iodine 123/technetium Tc 99m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism Am J Kidney Dis 45 344 352 10.1053/j.ajkd.2004.10.021 15685513 (Pubitemid 40431061)
66. D Fuster J Ybarra J Ortin JV Torregrosa R Gilabert X Setoain, et al. 2006 Role of pre-operative imaging using 99mTc-MIBI and neck ultrasound in patients with secondary hyperparathyroidism who are candidates for subtotal parathyroidectomy Eur J Nucl Med Mol Imaging 33 467 473 10.1007/s00259-005-0021- 2 16404597
67. C Jeanguillaume P Ureña E Hindié P Prieur M Pétrover V Menoyo-Calonge, et al. 1998 Secondary hyperparathyroidism: detection with I-123-Tc-99m-Sestamibi subtraction scintigraphy versus US Radiology 207 207 213 1:STN:280:DyaK1c7ptFeqtg%3D%3D 9580138
68. E Hindié D Mellière C Jeanguillaume P Ureña C deLabriolle-Vaylet L Perlemuter 2000 Unilateral surgery for primary hyperparathyroidism on the basis of technetium Tc 99m sestamibi and iodine 123 subtraction scanning Arch Surg 135 1461 1468 10.1001/archsurg.135.12.1461 11115353
69. DR Neumann CB Esselstyn Jr AM Madera 2000 Sestamibi/iodine subtraction single photon emission computed tomography in reoperative secondary hyperparathyroidism Surgery 128 22 28 10.1067/msy.2000.107065 1:STN:280:DC%2BD3czjs1ylsQ%3D%3D 10876181 (Pubitemid 30456891)
70. E Hindié O Ugur D Fuster M O'Doherty G Grassetto P Ureña, et al. 2009 2009 EANM parathyroid guidelines Eur J Nucl Med Mol Imaging 36 1201 1216 10.1007/s00259-009-1131-z 19471928
71. O Hessman P Stålberg A Sundin U Garske C Rudberg LG Eriksson, et al. 2008 High success rate of parathyroid reoperation may be achieved with improved localization diagnosis World J Surg 32 774 781 10.1007/s00268-008-9537- 5 18335276
72. D Rubello S Fanti C Nanni M Farsad P Castellucci S Boschi, et al. 2006 11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis Eur J Nucl Med Mol Imaging 33 453 459 10.1007/s00259-005-0008-z 16435115
73. D Casanova E Sarfati A De Francisco JA Amado M Arias C Dubost 1991 Secondary hyperparathyroidism: diagnosis of site of recurrence World J Surg 15 546 549 10.1007/BF01675660 1:STN:280:DyaK3MzmvVGntA%3D%3D 1891942
74. ML Richards GB Thompson DR Farley CS Grant 2008 Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring Am J Surg 196 937 942 10.1016/j.amjsurg.2008.07.022 19095113
75. A Cayo H Chen 2008 Radioguided reoperative parathyroidectomy for persistent primary hyperparathyroidism Clin Nucl Med 33 668 670 10.1097/RLU.0b013e318184b465 18806564